Talc Lawsuits Target New Defendant

April 11, 2017 – – The number of talc lawsuits filed in the last year has increased significantly. Manufacturer of talc based products, Johnson & Johnson has seen the brunt of the suits so far. With more than 3,000 cases filed throughout the United States to date, the pharmaceutical company is expected to be in litigation for quite some time. Now, a Chicago woman has added another defendant to the ever growing cases lineup.

Andrea Harris recently filed a claim against Johnson & Johnson, alleging that her long term use of talc based products has caused her to develop ovarian cancer. Harris has also added a new defendant, targeting popular pharmacy Walgreens in her case filing.

A representative for TalcumPowder.org says, “Harris’ lawsuit joins thousands of others across the nation against the pharmaceutical giant. The one difference in this and other cases, however, is that she is also going after Walgreens who sold her the products in question.”

Harris claims that she regularly purchased and used Shower-to-Shower and Johnson’s Baby Powder from Walgreens between 1980 and 2006. She was diagnosed in 2015 with ovarian cancer and is currently continuing treatment for the disease.

Her lawsuit not only names Walgreens as the seller of these products, but states that the company maintains a joint office in Buffalo Grove, Illinois, with Johnson & Johnson. The claim states that the two companies develop business plans together for marketing and distributing the two products manufactured by Johnson & Johnson that allegedly contain the talc powder that is being targeted for causing cancer.

“Harris’ lawsuit says that more than 20 studies, dating back to 1970 have shown a direct link between talc and ovarian cancer,” says the representative for talcumpowder.org. “The United States National Toxicology Platform found talc to be a carcinogen back in 1993, yet those products continued to be marketed and sold.”

Harris filed a claim that states negligence as well as breach of warranty and negligent misrepresentation because neither of the companies warned consumers about the risks of developing ovarian cancer after using talc products for a long period of time. The case also argues that given the studies provided, neither company took the initiative to pull those products from the shelves, continuing to market them to women for feminine hygiene uses.

###

Contact Drug-Lawsuits.org:

info@drug-lawsuits.org

ReleaseID: 60016904